SAB Biotherapeutics, Inc. - SABS
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 22
Latest filed: Jul 07, 2026
| Form | Count |
|---|---|
| 4 | 7 |
| 8-K | 6 |
| SCHEDULE 13G | 4 |
| SCHEDULE 13G/A | 3 |
| SCHEDULE 13D/A | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jul 07, 2026 | 8-K | Jul 07, 2026 | 0001193125-26-296936 | View |
| Jun 26, 2026 | 4 | Jun 25, 2026 | 0001193125-26-285722 | View |
| Jun 18, 2026 | 8-K | Jun 18, 2026 | 0001193125-26-275976 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001193125-26-226560 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0001727492-26-000011 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0001193125-26-225169 | View |
| May 04, 2026 | 8-K | Apr 28, 2026 | 0001193125-26-204125 | View |
| May 01, 2026 | SCHEDULE 13G | — | 0001104659-26-054220 | View |
| Apr 22, 2026 | 8-K | Apr 22, 2026 | 0001193125-26-168569 | View |
| Mar 25, 2026 | 4 | Mar 24, 2026 | 0001193125-26-124231 | View |
| Mar 23, 2026 | SCHEDULE 13D/A | — | 0001346824-26-000079 | View |
| Mar 19, 2026 | 8-K | Mar 17, 2026 | 0001193125-26-114730 | View |
| Mar 11, 2026 | SCHEDULE 13D/A | — | 0001346824-26-000072 | View |
| Mar 10, 2026 | 8-K | Mar 10, 2026 | 0001193125-26-099376 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001493215-26-000048 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0000921895-26-000472 | View |
| Feb 05, 2026 | 4 | Feb 03, 2026 | 0001193125-26-039508 | View |
| Feb 05, 2026 | 4 | Feb 03, 2026 | 0001193125-26-039524 | View |
| Feb 05, 2026 | 4 | Feb 03, 2026 | 0001193125-26-039537 | View |
| Feb 05, 2026 | 4 | Feb 05, 2026 | 0001193125-26-039564 | View |
| Feb 05, 2026 | 4 | Feb 03, 2026 | 0001193125-26-039577 | View |
| Jan 22, 2026 | SCHEDULE 13G | — | 0001193125-26-019535 | View |